tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Aptose’s Tuspetinib Shows Promising Results in AML Treatment Trial
Company AnnouncementsAptose’s Tuspetinib Shows Promising Results in AML Treatment Trial
3d ago
Aptose Secures $11.9M Loan for AML Therapy Development
PremiumCompany Announcements
Aptose Secures $11.9M Loan for AML Therapy Development
27d ago
Aptose Biosciences Announces Executive Retention Awards
PremiumCompany Announcements
Aptose Biosciences Announces Executive Retention Awards
2M ago
8K
Aptose Biosciences Secures Funding for Drug Development
PremiumCompany Announcements
Aptose Biosciences Secures Funding for Drug Development
2M ago
8K
Aptose Biosciences Appoints New Independent Auditor
PremiumCompany Announcements
Aptose Biosciences Appoints New Independent Auditor
2M ago
8K
Aptose Biosciences Reports Positive Early Data from TUSCANY Trial for AML Treatment
PremiumCompany AnnouncementsAptose Biosciences Reports Positive Early Data from TUSCANY Trial for AML Treatment
2M ago
Aptose Biosciences Reports Promising Q2 2025 Results
Premium
Company Announcements
Aptose Biosciences Reports Promising Q2 2025 Results
2M ago
Aptose Biosciences Advances Tuspetinib in AML Treatment with Promising Trial Results
Premium
Company Announcements
Aptose Biosciences Advances Tuspetinib in AML Treatment with Promising Trial Results
2M ago
Aptose Biosciences Advances TUSCANY Trial with Dose Escalation
PremiumCompany Announcements
Aptose Biosciences Advances TUSCANY Trial with Dose Escalation
2M ago
8K
Aptose Biosciences Appoints Ernst & Young as New Auditor
PremiumCompany Announcements
Aptose Biosciences Appoints Ernst & Young as New Auditor
3M ago
Aptose Biosciences Secures $2M Advance for AML Therapy
PremiumCompany Announcements
Aptose Biosciences Secures $2M Advance for AML Therapy
3M ago
8K
Aptose Biosciences Upgrades to OTCQB Market Listing
PremiumCompany Announcements
Aptose Biosciences Upgrades to OTCQB Market Listing
4M ago
Aptose Biosciences Defers Loan Interest Payments to Enhance Financial Flexibility
PremiumCompany AnnouncementsAptose Biosciences Defers Loan Interest Payments to Enhance Financial Flexibility
4M ago
Aptose Biosciences Secures $8.5M Loan Agreement
Premium
Company Announcements
Aptose Biosciences Secures $8.5M Loan Agreement
4M ago
8K
Aptose Biosciences Secures $8.5M Loan for AML Therapy
Premium
Company Announcements
Aptose Biosciences Secures $8.5M Loan for AML Therapy
4M ago
8K
Aptose Biosciences Secures Cash Advance Amid Financial Uncertainty
PremiumCompany Announcements
Aptose Biosciences Secures Cash Advance Amid Financial Uncertainty
4M ago
Aptose Biosciences Reports Promising Results from TUSCANY Trial in AML
PremiumCompany Announcements
Aptose Biosciences Reports Promising Results from TUSCANY Trial in AML
4M ago
Aptose Biosciences Approves Key Resolutions at Shareholder Meeting
PremiumCompany Announcements
Aptose Biosciences Approves Key Resolutions at Shareholder Meeting
5M ago
8K
Aptose Biosciences Begins 120 mg Dosing in TUSCANY Trial
PremiumCompany Announcements
Aptose Biosciences Begins 120 mg Dosing in TUSCANY Trial
5M ago
8K
Aptose’s TUSCANY Trial Data to be Presented at EHA 2025
PremiumCompany AnnouncementsAptose’s TUSCANY Trial Data to be Presented at EHA 2025
5M ago
Aptose Biosciences Reports Q1 2025 Financial Results
Premium
Company Announcements
Aptose Biosciences Reports Q1 2025 Financial Results
5M ago
Aptose Biosciences Reports Promising AML Trial Results and Expands Market Presence
Premium
Company Announcements
Aptose Biosciences Reports Promising AML Trial Results and Expands Market Presence
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >